SCHEMBL3780174

SCHEMBL3780174

O=C(OCC1c2ccccc2-c2ccccc21)N1CC[C@H](F)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
FABP5 Q01469 3/20 0.43
FABP7 O15540 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.42
EPHX2 P34913 1/20 0.41
BRD4 O60885 1/20 0.41
ALDH1A1 P00352 3/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
F10 P00742 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30449879 1.00 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL29911437 1.00 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL3783603 1.00 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL25257174 0.90 TSHR (0.38) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL30951907 0.86 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL30564450 0.86 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL3789075 0.86 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL3785639 0.86 KMT2A (0.44) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL27841040 0.85 KMT2A (0.48) KMT2AFABP5FABP7L3MBTL1TSHR
SCHEMBL15884802 0.84 SMN1; SMN2 (0.53) KMT2AFABP5FABP7L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100174096-A1 Methods for Production of Optically Active Fluoropyrrolidine Derivatives IM&T RESEARCH, INC. (US) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100174096-A1 Methods for Production of Optically Active Fluoropyrrolidine Derivatives QDPR, FDPS, DPYD KMT2A 4142/4885FABP5 1284/4885FABP7 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.